TAF7L antibody (Middle Region)
Quick Overview for TAF7L antibody (Middle Region) (ABIN925888)
Target
See all TAF7L AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Cross-Reactivity
- Rat (Rattus), Human
-
Immunogen
- TAF7 L antibody was raised in rabbit using the middle region of TAF7 as the immunogen
-
-
-
-
Application Notes
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
TAF7L Blocking Peptide, (ABIN937818), is also available for use as a blocking control in assays to test for specificity of this TAF7L antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- TAF7L (TAF7-Like RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor, 50kDa (TAF7L))
-
Alternative Name
- TAF7L
-
Background
- TAF7I belongs to the family of TATA box binding protein (Tbp)-associated factors. Promoter selectivity for all three classes of eukaryotic RNA polymerases is brought about by multimeric protein complexes containing TATA box binding protein (TBP) and specific TBP-associated factors (TAFs). Synonyms: Polyclonal TAF7L antibody, Anti-TAF7L antibody.
Target
-